Clinical significance of Helicobacter infection in children
|
|
- Marylou Watts
- 6 years ago
- Views:
Transcription
1 Clinical significance of Helicobacter infection in children Marion Rowland and Brendan Drumm Department of Paediatrics, University College Dublin, Children's Research Centre, Our Lady's Hospital for Sick Children, Crumlin, Dublin, Ireland Helicobacter pylori infection of the gastric mucosa causes chronic gastritis and is associated with peptic ulcer disease and gastric carcinoma. These are conditions which usually occur in adult life. However, H. pylori is an infection which is mainly acquired in childhood. The overall prevalence of H. pylori in children is 10% in developed countries but can be as high as 30-40% in children from lower socio-economic groups. In developing countries, the prevalence of H. pylori in children ranges from %. H. pylori gastritis does not appear to be associated with symptoms in children in the absence of duodenal ulcer disease. H. pylori infection is present in the vast majority of children with duodenal ulcer disease and, as in adults, eradication of the organism results in long-term healing of duodenal ulceration. H. pylori infection acquired in childhood is now considered to be a significant risk factor for the development of gastric carcinoma. The World Health Organization has classified H. pylori as a Group 1 carcinogen. Specific epidemiological questions which need to be answered in children include the age at which infection is acquired, specific risk factors for infection, the mode of transmission and the risk of reinfection following treatment. Recently, a one week treatment regimen using colloidal bismuth subcitrate, metronidazole and clarithromycin has been shown to be effective in treating children, but compliance is important. Currently there are no guidelines on the need to treat children and a consensus is urgently required on this issue. Correspondence to: Dr Marion Rowland, Department of Paediatrics, University College Dublin, Children's Research Centre, Our Lady's Hospital for Sick Children, Crumlin, Dublin 12, Ireland H. pylori is a Gram-negative spiral-shaped organism which is found within and beneath the mucous layer of the gastric epithelium 1 " 5. Colonisation of the gastric mucosa by H. pylori is associated with histological evidence of gastritis in adults and children 1 " 5. H. pylori is not an opportunistic coloniser of inflamed gastric tissue. Children with secondary gastritis due to Crohn's disease or eosinophilic gastritis are not colonised by H. pylori 3. In contrast, the majority of children with primary gastritis are colonised by the organism 3. The mucosal inflammatory infiltrate in children with H. pylori is different from that in adults, but is identical to that which occurs in animal models of Helicobacter infection. British Medical Bulletin 1998,54 (No. 1): C The British Council 1998
2 Helicobacter infection In children, there is predominantly a lymphocytic and plasma cell infiltrate with few neutrophils present 5. Epidemiology It has recently been recognised that H. pylori, like most enteric infections, is mainly acquired in childhood 3 ' 4-6 " 8. Adults rarely become infected with seroconversion rates varying between % per person year 7-8. The prevalence of infection increases with age from 10% at age 10 to 60% at age 60 in developed countries 3 * 4. The high prevalence seen in older age groups is consistent with a cohort phenomena, whereby infected adults acquired the infection as children 6-8 and infection is usually lifelong unless treated. As socio-economic conditions have improved in successive generations in the developed world, the prevalence of H. pylori has decreased. In developing countries, up to 100% of children are infected by 10 years of age 3-4. Cross sectional studies in developing countries indicate that young children are the group who become infected. Ethiopian children appear to become infected between 2 and 4 years of age with 60% of 4 year olds being infected 9. A study from Peru suggests that children are most likely to become infected between 18 and 30 months in developing countries 10. In contrast, the rate of acquisition of H. pylori infection in children over 5 years of age in a large Chinese study was 1% per year which was similar to the rate of acquisition of infection in adults 11. While, overall, only 10% of all children under the age of 10 years in developed countries are infected, the prevalence of infection is much greater among children in socially deprived families 3 ' 4. The presence of poor socio-economic conditions in childhood is a major risk factor for infection 3-4. Close personal contact, such as sharing a bed in childhood, may be important. However, it is difficult to separate overcrowding from poor sanitation, large sibships and bed sharing. In a US study, 30% of 3-5 year-olds and almost 50% of 6-10 year-olds in the lowest income group were infected 12. A recent study from Belfast found that 30% of children between 4 and 13 years of age, attending hospital for routine day case surgery, were seropositive for H. pylori with 32% of 6-7 yearolds being infected 13. In London, 23% of a group of 5 year-old school children were infected with H. pylori and there was only a very small increase in prevalence in the 8 year-old age group, suggesting that children had acquired the infection prior to school entry 14. Children under the age of 1 year rarely become infected in developed countries, even when exposed to infected mothers 15. Many groups have reported a high prevalence of H. pylori-speciiic IgG antibodies in the 96 British Medial Bulletin 1998;54 (No. 1)
3 Clinical significance of Helicobacter infection in children first 6 months of life which subsequently decline by 12 months 15. This represents maternal transfer of H. pylori specific antibodies to the fetus. There is no known natural reservoir of H. pylori. The mode of transmission is not known but this may be because most of the epidemiological studies have focused on adults who rarely become infected. There is marked clustering of infection among children within families 2 "*, and this has also been reported within institutions for mentally handicapped children 2-3. Person-to-person transmission, therefore, appears to be important, but it is not known if this is predominantly adult-to-child or child-to-child transmission. Faecal-oral transmission has been suggested, but difficulty in culturing H. pylori from faeces has greatly hampered investigation of faecal oral transmission 15. Oral-oral transmission may be possible, as H. pylori has on one occasion been cultured from saliva 15. Gastric-oral transmission has been postulated and, in children where reflux and vomiting are common, this mode of transmission requires further study. Reinfection following successful treatment of H. pylori is uncommon in adults in developed countries, ranging from 0.62% to 1.2% 15 annually. As infection occurs predominantly in children, the low reinfection rate in adults in developed countries is not surprising. Reinfection of children who have been successfully treated is much more likely as this is the group who acquire primary infection. Studies of children are necessary in order to assess accurately the risk of reinfection following treatment. This will help to determine if a vaccine is necessary or if antibiotic treatment is likely to be sufficient to eradicate H. pylori in the community. Duodenal ulcer disease Duodenal ulcer disease is associated with chronic gastritis and H. pylori is present on the gastric mucosa of almost all adults and children with duodenal ulcer disease 1 " 5. However, most people who are infected with H. pylori will not develop a duodenal ulcer. H. pylori will only colonise gastric mucosa and, therefore, its association with duodenal ulcer disease appears paradoxical. It has been hypothesised that H. pylori colonises areas of gastric metaplasia in the duodenum. In children, it has been shown that H. pylori infection of the antral mucosa and gastric metaplasia in the duodenum are independent risk factors for duodenal ulceration However, the co-existence in an individual of both H. pylori and gastric metaplasia results in a greatly increased risk of duodenal disease 17. Eradication of the organism from the gastric mucosa leads to long term healing of duodenal ulcer disease in children 3-4 as in adults 1. British Medical Bulletin 1998;54 (No. 1) 97
4 Helicobacter infection Gastric cancer Symptoms in children H. pylori has been classified as a Group 1 carcinogen by the World Health Organization 18. The relative risk of gastric carcinoma is times greater in infected adults compared to uninfected controls 19. The incidence of gastric cancer has decreased markedly over the past 30 years in developed countries, as has the prevalence of H. pylori gastritis 8 ' 19. Gastric cancer appears to be the end result of a progression from gastritis to gastric atrophy, intestinal metaplasia and dysplasia 19. Development of gastric atrophy is probably not the direct result of ageing, but the result of infection with H. pylori 20. Infection of the gastric mucosa in childhood may be a particular risk factor for the development of gastric carcinoma in adult life 21 ' 22. Strategies for the prevention of gastric cancer based on H. pylori eradication in adults are unlikely to be effective because of the long duration of infection in most adults. The prevention of infection in children would be a much more effective approach if this were possible. There is no significant evidence that H. pylori gastritis in the absence of duodenal ulcer disease is a cause of symptoms in children. H. pylori infection occurs frequently in asymptomatic children 2 "*' 12 " 14 ' 25 * 25. The clustering of H. pylori infection within families and the very high prevalence in underdeveloped countries also suggest that the infection is not associated with specific symptoms 2 " 4. In a recent meta-analysis, McArthur et al found that recurrent abdominal pain is not associated with an increased prevalence of H. pylori associated gastritis 23. H. pylori infected children cannot be differentiated from those who are not infected on the basis of their presenting symptoms 24. Furthermore H. pylori eradication was associated with an improvement in symptoms only in children who had duodenal ulcer disease but not in those with gastritis alone 25. This implies that the effect of H. pylori eradication on symptoms in these children relates to healing of duodenal ulcer disease rather than clearing of gastritis. Diagnosis of H. Pylori in children Endoscopy Upper gastrointestinal endoscopy and biopsy of the gastric mucosa has, until recently, been the investigation of choice for the diagnosis of H. 98 British Medical Bulletin 1998;54 (No. 1)
5 Clinical significance of Helicobacter infection in children pylori infection in children. The stomach is often reported as macroscopically normal in cases of H. pylori associated gastritis. More recently, a nodularity of the antral mucosa has been described in the majority of children with H. pylori gastritis 5. These nodules give the antrum a cobblestone appearance. This appearance is not usually seen in adults with H. pylori gastritis. The reason for this appearance of the gastric mucosa in association with H. pylori in children is unknown. Biopsies obtained from the gastric mucosa at endoscopy can be assessed for H. pylori infection by culture, histological examination and urease testing. Culture Culture of an antral biopsy is considered as the gold standard to confirm the presence of H. pylori on the gastric mucosa. However, it must be stressed that a very small number of colonies may be present on plates when gastric biopsies from children are cultured as compared to adults. Biopsy specimens may be cultured on Columbia blood agar (GEBCO) plates containing 7% (v/v) dehbrinated horse blood in an atmosphere of 5% O 2 and 10% CO r Organisms can then be identified as H. pylori on the basis of colony morphology, Gram stain, and the production of urease, oxidase and catalase. Histology Because of the characteristic appearance and unique location of H. pylori on the gastric mucosa, a presumptive diagnosis of H. pylori can be made by identifying spiral shaped organisms on gastric sections. The Warthin Starry silver stain is 100% sensitive and specific 3. A modified Giemsa stain is less expensive and easier to perform than the Warthin Starry silver stain and is also very sensitive in identifying H. pylori 3. Urease test As H. pylori produces high levels of the enzyme urease, this property can be used to screen for the presence of bacteria in antral biopsy specimens. In some children, because of the reduced number of bacteria, the colour reaction may take up to 24 h, and, on occasion, rapid urease tests have not been as sensitive as in adults 3-4. When a full biopsy specimen is placed in the urea medium, as against a fragment of the biopsy, the sensitivity of this test increases and is close to 100% 3. Serology The H. pylori specific serum IgG response has been reported as highly specific (99%) and sensitive (96%) in detecting children with H. pylori British Medial Bulletin 1998;54 (No. 1) 99
6 Helicobacter infection colonisation of the gastric antrum 3-4. This sensitivity and specificity varies considerably, however, depending on the assay employed 2 ' 15 * 26. It is important that ELISA assays used to diagnose H. pylori colonisation in children are standardised using children's sera. A positive serological response using an ELISA assay is generally defined as an optical density greater than 2 standard deviations above the mean value obtained for non colonised individuals. This cut off point is higher in adults than in children. If the assay is based on adult antibody levels, a significant number of children colonised with H. pylori will not be detected. Crabtree et ap 6 found that a H. pylori specific serum IgG assay based on adult cut off values was less than 50% sensitive in identifying colonised children. More recently, second generation serological tests have failed to diagnose up to 20% of children under 10 years of age 27. The mean antibody level in infected Chilean children under 10 years of age is significantly lower than infected children over 10 years of age 28. Furthermore, the pattern of serological response differs according to the antigen used and may take up to 60 days to develop in children 29. Following treatment for H. pylori infection, antibody levels may take 6 months or longer to return to normal in adults, and there is no data on serology testing in children following treatment. Measurement of H. pylori specific serum IgM and IgA antibodies in children are not a sensitive indicator of gastric colonisation 3. P 3 CJ-urea breath test The [ 13 C]-urea breath test (UBT) is an non-invasive test for the diagnosis of H. pylori infection. It is based on the fact that H. pylori produces large amounts of urease. When labelled urea is given to a patient who is infected with H. pylori, the urease enzyme splits the urea into ammonia and labelled carbon dioxide which can be measured in the expired breath. This test has been shown to be safe and highly sensitive and specific for the diagnosis of H. pylori infection in adults 30. It is also accurate in determining the success of treatment in eradicating H. pylori 30. The UBT has recently been shown to be 100% sensitive and 97.6% specific in the diagnosis of H. pylori infection in children 31. More importantly in terms of its use in children, a two hour fast is sufficient in this age group, and a test meal is not required. In fact a test meal may interfere with the sensitivity of the test in children. The UBT is also 100% sensitive and specific in children following treatment for H. pylori infection, and can easily replace the need for follow-up endoscopy in these children. 100 British Medical Bulletin 1998,54 (No. 1)
7 Clinical significance of Helicobacter infection in children Treatment in children In children, standard therapy has consisted of a bismuth containing preparation combined with one antibiotic for periods of 2-6 weeks 3. Compliance is a very important factor in achieving high eradication rates in children 32 * 33. The long duration of treatment, and the strong taste of ammonia which is associated with liquid bismuth, may reduce compliance. A combination of bismuth and amoxycillin eradicated H. pylori in approximately 70% of cases 15, while Gormally et ol eradicated the organism in 84% using metronidazole and bismuth for 2 weeks 17. More recently, a 1 week treatment regimen of colloidal bismuth subcitrate 480 mg/1.73 m 2 /day (maximum 120 mg qid), clarithromycin 7.5 mg/kg/day (maximum 250 bd), and metronidazole 20 mg/kg/day (maximum 200 mg tds) eradicated H. pylori in 21 out of 22 children % {95% CI: %) 33. Only 2 children had significant side effects of diarrhoea and vomiting. The shorter duration of treatment probably improved compliance as did the use of a Redidose Box (Redidose Company, Evolution Health Centre, 2 Sillwood Terrace, Brighton BN1 2LR, UK) with individual compartments for each dose of medication. It is questionable if this level of compliance could be achieved in routine practice and the effectiveness of a 1 week regimen needs to be assessed under such circumstances. Metronidazole resistance in an increasing problem in adults but is less common in children. However, it can occur and further studies are required in children of treatment regimens which do not include metronidazole. While concern has been expressed about the use of bismuth salts in children, none of the potential toxic side effects have been reported in children treated for H. pylori infection 3. Proton pump inhibitors are widely used in treatment regimens in adults but, as yet, there is no information on their usefulness in children. The National Institutes of Health consensus statement recommends that adults with gastric or duodenal ulcer disease who are infected with H. pylori should receive antimicrobial treatment for this infection 34. In children, long term remission of duodenal ulcer disease can also be achieved with antimicrobial regimens which eradicate H. pylori 3>Ai2. The necessity to treat H. pylori infection in the absence of duodenal ulcer disease in children is controversial. In the past, there has been no evidence to suggest that it is necessary to treat children with H. pylori infection in the absence of duodenal disease as H. pylori associated gastritis does not appear to be a cause of symptoms. This situation will have to be reviewed as evidence supporting an association between H. pylori infection and gastric carcinoma increases. Treatment of children may be the most cost effective method of reducing the prevalence of infection and the morbidity and mortality associated with H. pylori infection. British Medical Bulletin 1998;54 (No. 1) 101
8 Helicobacter infection Conclusion H. pylori is an infection which is acquired in childhood with the major risk factor for infection being poor socio-economic conditions. H. pylori gastritis alone is not a cause of symptoms in children. Duodenal ulcer disease in children is nearly always associated with H. pylori infection and long term healing of duodenal ulcers can be achieved by eradication of the organism. Recent studies indicate a strong association between H. pylori infection acquired during childhood and the development of gastric carcinoma in adult life. However, there are no guidelines at present in relation to the need to treat H. pylori in children, and it is vital that a consensus is achieved on this issue. References 1 Peterson WL. HelicobacUr pylori and peptic ulcer disease. N Engl J Med 1991; 324: Drumm B, Perez-Perez GI, Blaser MJ, Sherman PM. Imrafamihal clustering of Helicobacter pylori infection. N Engl J Med 1990; 322: Drumm B. Helicobacter pylori in the pediatric patient. Gastroenterol Clin North Am 1993; 22: Bourke B, Jones N, Sherman PM. Helicobacter pylori infection and peptic ulcer disease in children. Pediatr Infect Dis J 1996: 15: Hassall E, Dimmick JE. Unique features of Helicobacter pylori disease in children. Dig Dis Sci 1991; 36: Banatvala N, Mayo K, Megraud F, Jennings R, Decks JJ, Feldman RA. The cohort effect and Helicobacter pylori. J Infect Dis 1993; 168: Parsonnet J, Blaser MJ, Perez-Perez GI, Hargrett-Bean N, Tauxe RV. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology 1992; 102: Cullen DJE, Collins BJ, Christiansen KJ et al. When is Helicobacter pylori infection acquired? Gut 1993; 34: Lindkvist P, Asrat D, Nilsson I et al. Age at acquisition of Helicobacter pylori infection: comparison of a high and a low prevalence country. Scand] Infect Dis 1996; 28: Klein PD, Gilman RH, Leon-Barua R et al. The epidemiology of Helicobacter pylori in Peruvian children between 6 and 30 months of age. Am J Gastroenterol 1994; 89: Mitchell HM, Li YY, Hu PJ et al. Epidemiology of Helicobacter pylori in Southern China: identification of early childhood as a critical period for acquisition. / Infect Dis 1992; 166: Fiedorek SC, Malaty HM, Evans DL et al. Factors influencing the epidemiology of Helicobacter pylori infection in children. Pediatrics 1991; 88: McCallion WA, Ardill JE, Bamford KB, Potts SR, Boston VE. Age dependant hypergastrinaemia in children with Helicobacter pylori gastritis - evidence of early acquisition of infection. Gut 1995; 37: O'Donohoe JM, Sullivan PB, Scott R, Rogers T, Brueton MJ, Barltrop D. Recurrent abdominal pain and Helicobacter pylori in-a community-based sample of London children. Acta Paedtatr 1996; 85: Rowland M, Drumm B. Helicobacter pylori infection and peptic ulcer disease in children. Curr Opin Pediatr 1995; 7: Shabib S, Cutz E, Drumm B, Sherman P. Helicobacter pylori infection is associated with gastric metaplasia in the duodenum. Am] Clin Pathol 1994; 102: Gormally SM, Kierse B, Daly L, Bourke W, Durnin M, Drumm B. Gastric metaplasia and duodenal ulcer disease in children. Gut 1996; 38: British Medical Bulletin 1998;54 (No. 1)
9 Clinical significance of Helicobacter infection in children 18 International Agency for Research on Cancer. Scbistosomes, Liver Flukes and Helicobacter pylori. Monographs on the evaluation of carcinogenic risks to humans, vol 61. Lyon: IARC.1994; Forman D. Helicobacter pylori and gastric cancer. ScandJ Gastroenterol 1996; 31 (Suppl 220): Kuipers EJ, Uyterlinde AM, Pena AS et al. Long-term sequaelae of Helicobacter pylori gastritis. Lancet 1995; 345: Blaser MJ, Chyou PH, Nomura A. Age at establishment of Hehcobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res 1995, 55: Blaser MJ, Parsonnet J. Parasitism by the 'Slow' bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. / Clm Invest 1994; 94: Macarthur C, Saunders N, Feldman W. Helicobacter pylori, gastroduodenal disease, and recurrent abdominal pain in children. JAMA 1995; 273: Reifen R, Rasooly I, Sherman P, Murphy K, Drumm B. Helicobacter pylori infection in children. Is there specific symptomatology? Dig Dis Sci 1994; 39: Gormally SM, Parkash N, Durnin M et al. Association of symptoms with Helicobacter pylori infection in children. / Pediatr 1995; 126: Crabtree JE, Mahony MJ, Taylor JD, Heatley RV, Littlewood JM, Tompkins DS. Immune responses to Helicobacter pylori in children with recurrent abdominal pain. J Clin Pathol 1991; 44: Raymond J, Kalach N, Bergeret M et al. Evaluation of a serological test for diagnosis of Helicobacter pylori infection in children. Eur J Clm Microbiol Infect Dis 1996; 15: Russell RG, Wasserman SS, O'Donnoghue JM et al. Serologic response to Helicobacter pylon among children and teenagers in northern Chile. Am J Trop Med Hyg 1993; 49: Mitchell HM, Hazell SL, Kolesnikow T, Mitchell J, Frommer D. Antigen recognition during progression from acute to chronic infection with a caga- positive strain of Helicobacter pylori. Infect Immun 1996; 64: Atherton JC, Spiller RC. The urea breath test for Helicobacter pylori. Gut 1994; 35: Rowland M, Lambert I, Gormally S et al. 13 C-urea breath test for the diagnosis of Helicobacter pylori infection in children / Pediatr 1997; 131: Israel D, Hassall E. Treatment and long term follow-up of Helicobacter pylori-associated duodenal ulcer disease in children. / Pediatr 1993; 123: Walsh D, Goggin N, Rowland M, Durnin M, Moriarty S, Drumm B. One week treatment for Helicobacter pylori infection. Arch Dis Child 1997; 76: National Institutes of Health. Helicobacter pylori in peptic ulcer disease. NIH Consensus Statement 1994; 12: 1-23 British Medical Bulletin 1998;54 (No. 1) 103
Helicobacter pylori causes antral gastritis and is associated. Low Rates of Helicobacter pylori Reinfection in Children. Materials and Methods
GASTROENTEROLOGY 1999;117:336 341 Low Rates of Helicobacter pylori Reinfection in Children MARION ROWLAND,* DEEPAK KUMAR,* LESLIE DALY, PAMELA O CONNOR, DAVID VAUGHAN, and BRENDAN DRUMM*, *Department of
More informationGastric metaplasia and duodenal ulcer disease in children infected by Helicobacter pylori
Gut 1996;38: 513-517 Gastric metaplasia and duodenal ulcer disease in children infected by Helicobacter pylori 513 Department of Paediatrics S M Gormally B Bourke B Drumm and Public Health Medicine and
More informationHelicobacter pylori:an Emerging Pathogen
Bacteriology at UW-Madison Bacteriology 330 Home Page Helicobacter pylori:an Emerging Pathogen by Karrie Holston, Department of Bacteriology University of Wisconsin-Madison Description of Helicobacter
More informationHelicobacter and gastritis
1 Helicobacter and gastritis Dr. Hala Al Daghistani Helicobacter pylori is a spiral-shaped gram-negative rod. H. pylori is associated with antral gastritis, duodenal (peptic) ulcer disease, gastric ulcers,
More informationHelicobacter 2008;13:1-6. Am J Gastroent 2007;102: Am J of Med 2004;117:31-35.
An Update on Helicobacter pylori and Its Treatment Trenika Mitchell, PharmD, BCPS Clinical Assistant Professor University of Kentucky College of Pharmacy October 18, 2008 Objectives Review the epidemiology
More informationHelicobacter Pylori Testing HELICOBACTER PYLORI TESTING HS-131. Policy Number: HS-131. Original Effective Date: 9/17/2009
Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. Missouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,
More informationAcid-Peptic Diseases of the Stomach and Duodenum Including Helicobacter pylori and NSAIDs Prof. Sheila Crowe
Acid-Peptic Diseases of the Stomach and Duodenum Including Helicobacter pylori and NSAIDs 1 Division of Gastroenterology UC San Diego School of Medicine Clinical presentations of Helicobacter pylori infection
More informationManagement of dyspepsia and of Helicobacter pylori infection
Management of dyspepsia and of Helicobacter pylori infection The University of Nottingham John Atherton Wolfson Digestive Diseases Centre University of Nottingham, UK Community management of dyspepsia
More informationComparative study of invasive methods for diagnosis of Helicobacter pylori in humans
ISSN: 2319-7706 Volume 2 Number 7 (2013) pp. 63-68 http://www.ijcmas.com Original Research Article Comparative study of invasive methods for diagnosis of Helicobacter pylori in humans V.Subbukesavaraja
More informationUrea Breath Test for Diagnosis of Helicobactor pylori. Original Policy Date 12:2013
MP 2.04.04 Urea Breath Test for Diagnosis of Helicobactor pylori Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date 12:2013 Return to Medical Policy Index
More informationCorrelation Between Endoscopic and Histological Findings in Different Gastroduodenal Lesion and its Association with Helicobacter Pylori
ORIGINAL ARTICLE Correlation Between Endoscopic and Histological Findings in Different Gastroduodenal Lesion and its Association with Helicobacter Pylori *A. Sultana 1, SM Badruddoza 2, F Rahman 3 1 Dr.
More informationThe Nobel Prize in Physiology or Medicine for 2005
The Nobel Prize in Physiology or Medicine for 2005 jointly to Barry J. Marshall and J. Robin Warren for their discovery of "the bacterium Helicobacter pylori and its role in gastritis and peptic ulcer
More informationDisclosures. Co-founder and Chief Science Officer, TechLab
H. pylori testing Disclosures Co-founder and Chief Science Officer, TechLab Learning Objectives Evaluate the appropriate testing methodology by balancing performance, economics, and workflow. Discuss the
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/48400
More informationTHE PREVALENCE OF HELICBACTER PYLORI AMONG PATIENTS COMPLAINING FROM ABDOMINAL PAIN
THE PREVALENCE OF HELICBACTER PYLORI AMONG PATIENTS COMPLAINING FROM ABDOMINAL PAIN Ahed J. Al-Khatib Jordan University of Science and Technology, Jordan Ahmed Saber Abu-zaiton Al-albayt University Abstract
More informationValue of Serology as a Noninvasive Method for Evaluating the Efficacy of Treatment of Helicobacter pylori Infection
1038 Value of Serology as a Noninvasive Method for Evaluating the Efficacy of Treatment of Helicobacter pylori Infection Guillermo I. Pérez-Pérez, Alan F. Cutler, and Martin J. Blaser From the Division
More information594 Lewin, Weinstein, and Riddell s Gastrointestinal Pathology and Its Clinical Implications
594 Lewin, Weinstein, and Riddell s Gastrointestinal Pathology and Its Clinical Implications Figure 13-20. Stages in the natural history of H. pylori. Biopsies from the antrum are on the left and the oxyntic
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: helicobacter_pylori_testing 01/01/2019 N/A 01/01/2020 01/01/2019 Policy Effective April 1, 2019 Description
More informationCampylobacter like organisms on the gastric mucosa:
J Clin Pathol 1984;37:1002-1006 Campylobacter like organisms on the gastric mucosa: culture, histological, and serological studies DM JONES,* AM LESSELLS,t JOAN ELDRIDGE* From the *Public Health Laboratory
More informationHelicobacter Connections. Barry Marshall
Helicobacter Connections Barry Marshall The greatest obstacle to knowledge is not ignorance, it is the illusion of knowledge. Daniel Boorstein - Historian Peptic Ulcers Duodenal Ulcer (DU) Gastric Ulcer
More informationWhat is the status of Sequential Therapy Versus Standard Triple- Drug Therapy in peptic ulcer disease in eradicating H pylori?
What is the status of Sequential Therapy Versus Standard Triple- Drug Therapy in peptic ulcer disease in eradicating H pylori? Sequential Therapy Versus Standard Triple- Drug Therapy for Helicobacter pylori
More informationSequioa Education Systems, Inc. 1
Functional Diagnostic Medicine Training Program Module 2 The Functional Diagnostic Medicine Approach in the Treatment of Gastrointestinal Dysfunction and Disease Dr. Wayne L. Sodano, D.C., D.A.B.C.I. &
More informationH. pylori Antigen ELISA Kit
H. pylori Antigen ELISA Kit Catalog Number KA3142 96 assays Version: 04 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle of
More informationGilles Jequier. Commercial Director Organobalance, a Novozymes Company
"Latest clinical Evidences showing that a proprietary Lactobacillus reuteri Strain can reduce the Symptoms associated with a Helicobacter pylori Infection" Gilles Jequier Commercial Director Organobalance,
More information- Helicobacter - THE EASE AND DIFFICULTY OF A NEW DISCOVERY. Robin Warren
- Helicobacter - THE EASE AND DIFFICULTY OF A NEW DISCOVERY Robin Warren EARLY DAYS First reports 100 years ago considered spirochaetes 1940 Freedburg saw curved organisms in the stomach 1954 Palmer: Freedburg
More informationHelicobacter pylori Eradication Therapy Success Regarding Different Treatment Period Based on Clarithromycin or Metronidazole Triple-Therapy Regimens
Helicobacter ISSN 1523-5378 Filipec Blackwell Oxford, HEL 1083-4389 1523-5378 Journal XXX Original H. 2008 pylori Kanizaj compilation The UK Eradication Publishing Article Authors et al. Ltd 2008 Therapy
More informationMagaji et al., Afr. J. Infect. Dis. 2(2): THE ROLE OF AN AGGRESSIVE FACTOR IN PEPTIC ULCER DISEASE (PUD)
Magaji et al., Afr. J. Infect. Dis. 2(2): 80-84 80 Review Paper ISSN: 2006-0165 2008 THE ROLE OF AN AGGRESSIVE FACTOR IN PEPTIC ULCER DISEASE (PUD) Magaji, R.A. 1,b *, Tanko, Y. 2 and Magaji, G.M. 3 Afr.
More informationCOMPARISON OF ONCE-A-DAY VERSUS TWICE-A-DAY CLARITHROMYCIN IN TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION
Phil J Gastroenterol 2006; 2: 25-29 COMPARISON OF ONCE-A-DAY VERSUS TWICE-A-DAY CLARITHROMYCIN IN TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION Marianne P Collado, Ma Fatima P Calida, Peter P Sy,
More informationResearch Article Performance of Routine Helicobacter pylori Invasive Tests in Patients with Dyspepsia
Gastroenterology Research and Practice Volume 2013, Article ID 184806, 5 pages http://dx.doi.org/10.1155/2013/184806 Research Article Performance of Routine Helicobacter pylori Invasive Tests in Patients
More informationPEPTIC ULCER DISEASE JOHN R SALTZMAN, MD. Director of Endoscopy Brigham and Women s Hospital Professor of Medicine Harvard Medical School
PEPTIC ULCER DISEASE JOHN R SALTZMAN, MD Director of Endoscopy Brigham and Women s Hospital Professor of Medicine Harvard Medical School No disclosures Disclosures Overview Causes of peptic ulcer disease
More informationTable 2.9. Case control studies of helicobacter pylori infection and oesophageal adenocarcinoma
Characteristics of Characteristics of controls Detection Chow et al (1998) 1993-1995 129 of newly diagnosed oesophageal/gastric cardia (OGC) adenocarcinoma. 224 population controls selected by random digit
More informationÐÑÏÓÊÅÊËÇÌÅÍÅÓ ÎÅÍÏÃËÙÓÓÅÓ ÁÍÁÊÏÉÍÙÓÅÉÓ ÅËËÇÍÙÍ ÅÑÅÕÍÇÔÙÍ
ÐÑÏÓÊÅÊËÇÌÅÍÅÓ ÎÅÍÏÃËÙÓÓÅÓ ÁÍÁÊÏÉÍÙÓÅÉÓ ÅËËÇÍÙÍ ÅÑÅÕÍÇÔÙÍ 205 206 ÐÑÏÓÊÅÊËÇÌÅÍÅÓ ÎÅÍÏÃËÙÓÓÅÓ ÁÍÁÊÏÉÍÙÓÅÉÓ ÅËËÇÍÙÍ ÅÑÅÕÍÇÔÙÍ EPITHELIAL CELL TURNOVER IN NON-DYSPLASTIC GASTRIC MUCOSA ADJACENT TO EARLY AND
More informationHelicobacter pylori: Diagnosis, treatment and risks of untreated infection
Helicobacter pylori: Diagnosis, treatment and risks of untreated infection Klaus Mönkemüller Department of Gastroenterology, Hepatology und Infectius Diseases Otto-von-Guericke University, Magdeburg bb
More information~Helicobacter pylori, gastritis, and peptic ulceration
17 Department of Pathology J I Wyatt Department of Medicine T M Shallcross J E Crabtree RV Heatley St James University Hospital, Leeds LS9 7TF Correspondence to: Dr J I Wyatt. Accepted for publication
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Adherence, to bismuth quadruple therapy, 543 546 Adjuvant therapy, probiotics as, 567 569 Age factors, in gastric cancer, 611 612, 616 AID protein,
More informationUtility of In House made Rapid Urease Broth Test for Detection of Helicobacter pylori Infection in Resource Constraint Settings
Original article: Utility of In House made Rapid Urease Broth Test for Detection of Helicobacter pylori Infection in Resource Constraint Settings 1.Dr. Swati Rahul Dhope, 2. Dr. Sachinkumar Vasantrao Wankhede
More informationH. pylori IgM. Cat # H. pylori IgM ELISA. ELISA: Enzyme Linked Immunosorbent Assay. ELISA - Indirect; Antigen Coated Plate
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com H. pylori
More informationH.pylori IgA Cat #
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
More informationH. pylori IgM CLIA kit
H. pylori IgM CLIA kit Cat. No.:DEEL0251 Pkg.Size:96 tests Intended use Helicobacter pylori IgM Chemiluminescence ELISA is intended for use in evaluating the serologic status to H. pylori infection in
More informationFecoprevalence and determinants of Helicobacter pylor infection among asymptomatic children in Myanmar
International Journal of Gastroenterology, Hepatology, Transplant & Nutrition Original Article Fecoprevalence and determinants of Helicobacter pylor infection among asymptomatic children in Myanmar Hnin
More informationThe usual dose is 40 mg daily with amoxycillin 1.5 g (750 mg b.d.) for 2 weeks. Up to 2 g/day of amoxycillin has been used in clinical trials.
Name Gasec - 2 Gastrocaps Composition Gasec-20 Gastrocaps Each Gastrocaps contains: Omeprazole 20 mg (in the form of enteric-coated pellets) Properties, effects Proton Pump Inhibitor Omeprazole belongs
More informationComparison of the Accuracy of Two Commercial Rapid Urase Tests, CLOtest and Pronto Dry, in Detecting Helicobacter pylori Infection ABSTRACT
Original Article Rojborwonwitaya J, Vijitjunyakul N THAI J GASTROENTEROL 2005 Vol. 6 No. 2 May - Aug. 2005 55 Comparison of the Accuracy of Two Commercial Rapid Urase Tests, CLOtest and Pronto Dry, in
More informationA PLACEBO CONTROLLED TRIAL OF BISMUTH SALICYLATE IN HELICOBACTER PYLORI ASSOCIATED GASTRITIS
A PLACEBO CONTROLLED TRIAL OF BISMUTH SALICYLATE IN HELICOBACTER PYLORI ASSOCIATED GASTRITIS Pages with reference to book, From 154 To 156 Javed Iqbal Kazi, Naeem Aon Jafarey, Syed Mahmood Alam ( Department
More informationH.Pylori IgM Cat # 1504Z
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
More informationAnalysis of Helicobacter pylori vaca and caga genotypes and serum antibody profile in benign and malignant gastroduodenal diseases
182 Department of Laboratory Medicine D Basso F Navaglia L Brigato M G Piva A Toma E Greco G Roveroni M Plebani Department of Gastroenterology F Di Mario II Divisione Chirurgica, University Hospital of
More informationH.Pylori IgG
DIAGNOSTIC AUTOMATION, INC. 21250 Califa Street, Suite 102 and116, Woodland Hills, CA 91367 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com
More informationH.Pylori IgG Cat # 1503Z
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
More informationThe New England Journal of Medicine. Patients
HELICOBACTER PYLORI INFECTION AND THE DEVELOPMENT OF GASTRIC CANCER NAOMI UEMURA, M.D., SHIRO OKAMOTO, M.D., SOICHIRO YAMAMOTO, M.D., NOBUTOSHI MATSUMURA, M.D., SHUJI YAMAGUCHI, M.D., MICHIO YAMAKIDO,
More informationHelicobacter pylori Improved Detection of Helicobacter pylori
DOI:http://dx.doi.org/10.7314/APJCP.2016.17.4.2099 RESEARCH ARTICLE Improved Detection of Helicobacter pylori Infection and Premalignant Gastric Mucosa Using Conventional White Light Source Gastroscopy
More informationPrevalence of Helicobacter pylori in Patients with End Stage Renal Disease
2000;20:97-102 Helicobacter pylori Prevalence of Helicobacter pylori in Patients with End Stage Renal Disease Do Ha Kim, M.D., Hwoon-Yong Jung, M.D., Suk-Kyun Yang, M.D. Weon-Seon Hong, M.D. and Young
More informationHelicobacter pylori 幽門螺旋桿菌 馬偕紀念醫院新竹分院一般內科, 肝膽腸胃科陳重助醫師
Helicobacter pylori 幽門螺旋桿菌 馬偕紀念醫院新竹分院一般內科, 肝膽腸胃科陳重助醫師 Hp : Helicobacter pylori Part 1. Pathophysiology and immune response Pathogenesis of Hp infection Part 2. Clinical manifestation Part 3. Dx tests for
More informationHelicobacter pylori Infection in Adults from a Poor Urban Community in Northeastern Brazil: Demographic, Lifestyle and Environmental Factors
BJID 2005; 9 (October) 405 Helicobacter pylori Infection in Adults from a Poor Urban Community in Northeastern Brazil: Demographic, Lifestyle and Environmental Factors Maria N. Rodrigues 1, Dulciene M.
More informationTreatment of Helicobacter pylori Infection
Treatment of Helicobacter pylori Infection Epidemiology of H. pylori infection (North America) Which are the high risk groups? Epidemiology of H. pylori infection (North America) Which are the high risk
More informationKEYWORDS Dyspepsia, Acid Peptic Disease, Helicobacter Pylori, Urease, Giemsa, Peptic Ulcer, Non-Ulcer Dyspepsia.
INCIDENCE OF HELICOBACTER PYLORI WITH ACID PEPTIC DISEASE AND MALIGNANT CONDITIONS OF UPPER GASTROINTESTINAL TRACT IN A TERTIARY CENTRE - A PROSPECTIVE STUDY Karunamoorthy Rajachidambaram 1, Dinkaran Kaarthesan
More informationType of intervention Diagnosis. Economic study type Cost-effectiveness analysis.
Noninvasive tests as a substitute for histology in the diagnosis of Helicobacter pylori infection Hahn M, Fennerty M B, Corless C L, Magaret N, Lieberman D A, Faigel D O Record Status This is a critical
More informationTRANSPARENCY COMMITTEE OPINION. 13 December 2006
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 13 December 2006 HELIKIT 75 mg, powder for oral solution CIP : 343 132-1 Applicant : MAYOLY SPINDLER 13 Curea anhydrous
More informationSee external label 2 C-8 C Σ=96 tests Cat # 1505Z. MICROWELL ELISA H.Pylori IgA Cat # 1505Z
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
More informationFraming Helicobacter pylori: The Etiology of Peptic Ulcers and Gastritis
Framing Helicobacter pylori: The Etiology of Peptic Ulcers and Gastritis By Aja Dunn Gastritis (inflammation of the stomach); Etiologic agent - Helicobacter pylori (1). Transmission H. pylori infection
More informationOriginal Article. Abstract
Original Article Association of helicobacter pylori with carcinoma of stomach Muhammad Arif, Serajuddaula Syed Department of Pathology, Sindh Medical College, Karachi Abstract Objective: To note the association
More informationHealth technology The use of four different combined treatments for Helicobacter pylori (H. pylori) infection. These were:
Tratamiento de la infeccion por Helicobacter pylori en pacientes con ulcera duodenal: estudio de costo-beneficio [Treatment of Helicobacter pylori infection in patients with duodenal ulcer: a cost-benefit
More informationCorrelation between Gastric Mucosal Morphologic Patterns and Histopathological Severity of
Hindawi Publishing Corporation BioMed Research International Volume 2015, Article ID 808505, 7 pages http://dx.doi.org/10.1155/2015/808505 Research Article Correlation between Gastric Mucosal Morphologic
More informationSuccess Rate of Furazolidone Based Triple Therapy for Eradication of Helicobacter Pylori in Children
Original Article Iran J Pediatr Sep 2008; Vol 19 (No 3), Pp:244-248 Success Rate of Furazolidone Based Triple Therapy for Eradication of Helicobacter Pylori in Children Mehri Najafi, MD* 1 ; Ahmad Khodadad,
More informationPrevalence of Helicobacter pylori Infection in Korean Children: Inverse Relation to Socioeconomic Status Despite a Uniformly High Prevalence in Adults
American Journal of Epidemiology Copyright 1996 by The Johns Hopkins University School of Hygiene and Public Health AD rights reserved Vol. 143, No. 3 Printed In U.SJL Prevalence of Helicobacter pylori
More informationSpecimens of Gastric Cancer: A Preliminary Evaluation in
Diagnostic and Therapeutic Endoscopy, Vol. 4, pp. 35-42 Reprints available directly from the publisher Photocopying permitted by license only (C) 1997 OPA (Overseas Publishers Association) Amsterdam B.V.
More informationMANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) Routine endoscopic investigation of patients of any age, presenting with dyspepsia
More informationHELICOBACTER PYLORI UPDATE
HELICOBACTER PYLORI UPDATE PROF. TAWHEED MOWAFY DEAN OF AZAL FACULTY OF MEDICINE INTRODUCTION (H. pylori) is recognised as the most common chronic human bacterial infection,1 affecting up to 50% of the
More informationThe significance of Helicobacter pylori in the approach of dyspepsia in primary care Arents, Nicolaas Lodevikus Augustinus
University of Groningen The significance of Helicobacter pylori in the approach of dyspepsia in primary care Arents, Nicolaas Lodevikus Augustinus IMPORTANT NOTE: You are advised to consult the publisher's
More informationA COMPARATIVE STUDY BETWEEN IMMUNOHISTOCHEMISTRY, HEMATOXYLIN & EOSIN AND GEIMSA STAIN FOR HELICOBACTER PYLORI DETECTION IN CHRONIC GASTRITIS
Original Research Article Pathology International Journal of Pharma and Bio Sciences ISSN 0975-6299 A COMPARATIVE STUDY BETWEEN IMMUNOHISTOCHEMISTRY, HEMATOXYLIN & EOSIN AND GEIMSA STAIN FOR HELICOBACTER
More informationCampylobacter pylori in non-specific abdominal pain in childhood
Gut, 1989, 3, 912-916 Serum pepsinogen I and IgG antibody to Campylobacter pylori in non-specific abdominal pain in childhood GIUSEPPINA ODERDA, D VAIRA, J HOLTON, J F DOWSETT, AND NICOLETTA ANSALDI From
More informationThe Association of CagA + Helicobacter pylori Infection and Gastric Carcinoma
The Association of CagA + Helicobacter pylori Infection and Gastric Carcinoma PRESENTER: Dr. Md. Khalilur Rahman Student of M.D.(Internal Medicine) Sylhet MAG Osmani Medical College Gastric Cancer- ranked
More informationHelicobacter pylori REGULAR REVIEW. epithelium.3 This adherence is associated with. Spiral organisms have been noted on the gastric
1278 Archives ofdisease in Childhood 1990; 65: 1278-1282 REGULAR REVIEW Department of Paediatrics, University College Dublin Correspondence to: Professor B Drumm, Our Lady's Hospital for Sick Children,
More informationACG Clinical Guideline: Treatment of Helicobacter pylori Infection
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection William D. Chey, MD, FACG 1, Grigorios I. Leontiadis, MD, PhD 2, Colin W. Howden, MD, FACG 3 and Steven F. Moss, MD, FACG 4 1 Division
More informationEfficacy of Proton Pump Inhibitor-based Triple Therapy and Bismuth-based Quadruple Therapy for Helicobacter pylori Eradication in Korean Children
pissn: 2234-8646 eissn: 2234-8840 http://dx.doi.org/10.5223/pghn.2012.15.4.237 Pediatric Gastroenterology, Hepatology & Nutrition 2012 December 15(4):237-242 Original Article PGHN Efficacy of Proton Pump
More informationPeptic Ulcer Disease Update
Peptic Ulcer Disease Update Col Pat Storms RAM 2005 Disclosure Information 84th Annual AsMA Scientific Meeting Col Patrick Storms I have no financial relationships to disclose. I will discuss the following
More informationA Heaney, J S A Collins, RGPWatson, R J McFarland, K B Bamford, T C K Tham
186 Royal Victoria Hospital, Belfast, A Heaney J S A Collins Department of Medicine, Queen s University, Belfast, RGPWatson Ulster Hospital, Dundonald, R J McFarland T C K Tham Department of Microbiology
More informationDERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA o Patients of any age with ALARM signs should be referred through the 2-week referral system o Routine endoscopic investigation
More informationEDUCATION PRACTICE. Persistent Helicobacter pylori Infection After a Course of Antimicrobial Therapy What s Next? Clinical Scenario.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2008;6:1086 1090 EDUCATION PRACTICE Persistent Helicobacter pylori Infection After a Course of Antimicrobial Therapy What s Next? RICHARD J. SAAD* and WILLIAM D.
More informationGASTROINTESTINAL AND ANTIEMETIC DRUGS. Submitted by: Shaema M. Ali
GASTROINTESTINAL AND ANTIEMETIC DRUGS Submitted by: Shaema M. Ali GASTROINTESTINAL AND ANTIEMETIC DRUGS by: Shaema M. Ali There are four common medical conditions involving the GI system 1) peptic ulcers
More information(Received September 12, Accepted April 23, 1997) Jpn. J. Med. Sci. Biol., 50, 55-62, 1997.
Jpn. J. Med. Sci. Biol., 50, 55-62, 1997. EVALUATION OF CULTURE, HISTOLOGICAL EXAMINATION, SEROLOGY AND THE RAPID UREASE TEST FOR DIAGNOSIS OF HELICOBACTER PYLORI IN PATIENTS WITH DYSPEPSIA IN BANGLADESH
More informationpylori positive patients with duodenal ulcer
Gut 1996; 39: 629-633 629 PAPERS Prevalence of Helicobacter pylori infection and related gastroduodenal lesions in spouses of Helicobacter pylori positive patients with duodenal ulcer F Parente, G Maconi,
More informationOriginal Article. Is There Any Association between Helicobacter pylori CagA Status and Patient's Habits with Gastric Carcinoma
Faridpur Med. Coll. J. 2015;10(1):09-13 Original Article Is There Any Association between Helicobacter pylori CagA Status and Patient's Habits with Gastric Carcinoma MA Hassan 1, MA Ahad 2, MH Rahman 3,
More informationEffect of sibling number in the household and birth order on prevalence of Helicobacter pylori: a cross-sectional study
Published by Oxford University Press on behalf of the International Epidemiological Association ß The Author 2007; all rights reserved. Advance Access publication 28 September 2007 International Journal
More informationin Pregnancy ABSTRACT
Infectious Diseases in Obstetrics and Gynecology 7:195-198 (1999) (C) 1999 Wiley-Liss, Inc. Increased Susceptibility to Helicobacter pylori Infection in Pregnancy S. Lanciers,,2 B. Despinasse, 1 D.I. Mehta,
More informationSeroconversion and seroreversion in IgG antibodies to Helicobacter pylori: a serology based prospective cohort study
444 Copenhagen County Centre of Preventive Medicine, Glostrup University Hospital, Glostrup, Denmark S Rosenstock T Jørgensen Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark L
More informationUpdate on the pathological classification of gastritis. Hala El-Zimaity, M.D. M.S. Epidemiology McMaster University Hamilton, Ontario Canada
Update on the pathological classification of gastritis Hala El-Zimaity, M.D. M.S. Epidemiology McMaster University Hamilton, Ontario Canada CLASSIFICATION GASTRITIS GASTROPATHY 1. Acute 2. Chronic 3. Uncommon
More informationImmunoglobulin G Antibody against Helicobacter pylori: Clinical Implications of Levels Found in Serum
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, Sept. 2002, p. 1044 1048 Vol. 9, No. 5 1071-412X/02/$04.00 0 DOI: 10.1128/CDLI.9.5.1044 1048.2002 Copyright 2002, American Society for Microbiology. All Rights
More informationEndoscopic atrophic classification before and after H. pylori eradication is closely associated with histological atrophy and intestinal metaplasia
E311 before and after H. pylori eradication is closely associated with histological atrophy and intestinal metaplasia Authors Institution Masaaki Kodama, Tadayoshi Okimoto, Ryo Ogawa, Kazuhiro Mizukami,
More informationClinical importance of Campylobacter pyloridis and associated serum IgG and IgA antibody responses in
J Clin Pathol 1986;39:215-219 Clinical importance of Campylobacter pyloridis and associated serum IgG and IgA antibody responses in patients undergoing upper gastrointestinal endoscopy LINDA BOOTH, G HOLDSTOCK,
More informationClinical Policy Title: Noninvasive testing for H. pylori
Clinical Policy Title: Noninvasive testing for H. pylori Clinical Policy Number: 08.01.05 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: August 17, 2017 Next
More informationClinical Policy Title: Noninvasive testing for H. pylori
Clinical Policy Title: Noninvasive testing for H. pylori Clinical Policy Number: 08.01.04 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: August 17, 2016 Next
More informationC urea breath test. J E Thomas
Gut 1998;43(suppl 3):S7 S12 S7 C urea breath test J E Thomas Department of Child Health, Sir James Spence Institute of Child Health, Royal Victoria Infirmary, Newcastle upon Tyne, UK Helicobacter pylori
More informationCyclooxygenase-2 Expression in Gastric Antral Mucosa Before and After Eradication of Helicobacter pylori Infection
THE AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 94, No. 5, 1999 1999 by Am. Coll. of Gastroenterology ISSN 0002-9270/99/$20.00 Published by Elsevier Science Inc. PII S0002-9270(99)00126-4 Cyclooxygenase-2
More informationRapidity of diagnosis and management of H. Pylori in the endoscopy unit at Mater Dei Hospital
Rapidity of diagnosis and management of H. Pylori in the endoscopy unit at Mater Dei Hospital Abstract Introduction: H.pylori infection has been associated with various gastric pathologies and its prevalence
More informationHistopathology: gastritis and peptic ulceration
Histopathology: gastritis and peptic ulceration These presentations are to help you identify, and to test yourself on identifying, basic histopathological features. They do not contain the additional factual
More informationEfficacy of standard triple therapy versus bismuth-based quadruple therapy for eradication of Helicobacter Pylori infection
Efficacy of standard triple therapy versus bismuth-based quadruple therapy for eradication of Helicobacter Pylori infection Ramin Talaie Modarress Hospital, Shahid Beheshti University of Medical Sciences,
More informationH. pylori Stool Rapid Test (Cassette)
H. pylori Stool Rapid Test (Cassette) Cat. No.:DTS590 Pkg.Size: Intended use The H. pylori Stool Cassette is an immunochromatographic screening assay for the qualitative detectionof Helicobacter pylori
More informationEMILOK Global. (omeprazole) Composition: Each capsule contains 20 mg omeprazole as enteric-coated
EMILOK Global (omeprazole) Composition: Each capsule contains 20 mg omeprazole as enteric-coated granules. Properties: Emilok (omeprazole) belongs to the group of proton pump inhibitors, inhibits both
More information